These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7083248)

  • 1. Phase II trial of tamoxifen in malignant melanoma.
    Leichman CG; Samson MK; Baker LH
    Cancer Treat Rep; 1982 Jun; 66(6):1447. PubMed ID: 7083248
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of tamoxifen in patients with metastatic malignant melanoma.
    Telhaug R; Klepp O; Børmer O
    Cancer Treat Rep; 1982 Jun; 66(6):1437. PubMed ID: 7083247
    [No Abstract]   [Full Text] [Related]  

  • 3. Tamoxifen in the treatment of metastatic malignant melanoma.
    Wagstaff J; Thatcher N; Rankin E; Crowther D
    Cancer Treat Rep; 1982 Sep; 66(9):1771. PubMed ID: 7116353
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study of tamoxifen in patients with disseminated malignant melanoma.
    Creagan ET; Ingle JN; Green SJ; Ahmann DL; Jiang NS
    Cancer Treat Rep; 1980; 64(2-3):199-201. PubMed ID: 7407752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen in metastatic malignant melanoma.
    Meyskens FL; Voakes JB
    Cancer Treat Rep; 1980 Jan; 64(1):171-3. PubMed ID: 7379053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of mitolactol in advanced malignant melanoma.
    Murray N; Silver H; Shah A; Wilson K
    Cancer Treat Rep; 1985 Jun; 69(6):723-4. PubMed ID: 4016778
    [No Abstract]   [Full Text] [Related]  

  • 7. Tamoxifen in the treatment of malignant melanoma.
    Masiel A; Buttrick P; Bitran J
    Cancer Treat Rep; 1981; 65(5-6):531-2. PubMed ID: 7237476
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of an anti-estrogen, tamoxifen, in the treatment of metastatic malignant melanoma].
    Quencez E; Blanc D; Adessi G; Agache P; Laurent R
    Ann Dermatol Venereol; 1985; 112(4):341-6, 349. PubMed ID: 4026132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
    McClay EF; McClay ME; Monroe L; Baron PL; Cole DJ; O'Brien PH; Metcalf JS; Maize JC
    Br J Cancer; 2000 Jul; 83(1):16-21. PubMed ID: 10883662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of i.v. menogaril in patients with malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group Study.
    McCulloch PB; Eisenhauer EA; Shibata HR; Young VP
    Cancer Treat Rep; 1987; 71(7-8):771-2. PubMed ID: 2955887
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.
    Lopez M; Di Lauro L; Papaldo P; Ganzina F; Di Pietro N; Lazzaro B
    Cancer Treat Rep; 1986 Jul; 70(7):911-2. PubMed ID: 3459575
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II study of an aziridinylbenzoquinone (AZQ) in disseminated malignant melanoma.
    Creagan ET; Schutt AJ; Ahmann DL; Green SJ
    Cancer Treat Rep; 1982 Dec; 66(12):2089-90. PubMed ID: 7139650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cis-diamminedichloroplatinum in the treatment of disseminated malignant melanoma.
    Mechl Z; Krejcí P
    Neoplasma; 1983; 30(3):371-7. PubMed ID: 6683360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant melanoma: tamoxifen and oestrogen receptors.
    Furnival CM; Gough IR; Thynne GS
    Lancet; 1981 Aug; 2(8242):374-5. PubMed ID: 6115153
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of mitomycin in disseminated malignant melanoma.
    Creagan ET; Edmonson JH; Ahmann DL; Chang M
    Cancer Treat Rep; 1985 Dec; 69(12):1451-2. PubMed ID: 4075321
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapy of generalized skin melanoma].
    Dement'eva NP; Koroleva LA
    Sov Med; 1981; (10):103-6. PubMed ID: 7313762
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma.
    Creagan ET; Ingle JN; Ahmann DL; Green SJ
    Cancer; 1982 Apr; 49(7):1353-4. PubMed ID: 7059950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II evaluation of spirogermanium in malignant melanoma: a Southwest Oncology Group Study.
    Goodwin JW; Kopecky K; Slavik M; Tranum BL; Balcerzak SP; Fletcher WS; Costanzi JJ
    Cancer Treat Rep; 1987 Oct; 71(10):985-6. PubMed ID: 3652061
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II trial of VM-26 in patients with metastatic malignant melanoma.
    Bellet RE; Catalno RB; Mastrangelo MJ; Berd D; Koons LS
    Cancer Treat Rep; 1978 Mar; 62(3):445-7. PubMed ID: 348313
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II study of maytansine and chlorozotocin in patients with disseminated malignant melanoma.
    Ahmann DL; Frytak S; Kvols LK; Hahn RG; Edmonson JH; Bisel HF; Creagan ET
    Cancer Treat Rep; 1980; 64(4-5):721-3. PubMed ID: 6448689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.